DarioHealth Corp. (DRIO) › Shareholders' EquityDarioHealth Corp. (DRIO) — Shareholders' EquityAnnual figures by period end, from SEC filings.2011-08-10: $02011-12-31: $193.1K2012-12-31: -$1.07M2013-12-31: -$86.0K2014-12-31: -$5.29M2015-12-31: -$1.58M2016-12-31: -$6.54M2017-12-31: $3.94M2018-12-31: $8.93M2019-12-31: $18.89M2020-12-31: $28.15M2021-12-31: $85.55M2022-12-31: $80.00M2023-12-31: $58.14M2024-12-31: $72.02M2025-12-31: $67.92M$67.92M2011-08-10Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$67.92M-5.7%2026-03-19Balance as of period end2024-12-31$72.02M+23.9%2026-03-19Balance as of period end2023-12-31$58.14M-27.3%2026-03-19Balance as of period end2022-12-31$80.00M-6.5%2025-03-10Balance as of period end2021-12-31$85.55M+203.9%2024-03-28Balance as of period end2020-12-31$28.15M+49.0%2023-03-09Balance as of period end2019-12-31$18.89M+111.7%2022-03-22Balance as of period end2018-12-31$8.93M+126.5%2021-03-09Balance as of period end2017-12-31$3.94M—2020-03-17Balance as of period end2016-12-31-$6.54M—2019-03-25Balance as of period end2015-12-31-$1.58M—2018-03-19Balance as of period end2014-12-31-$5.29M—2017-03-22Balance as of period end2013-12-31-$86.0K—2016-02-08Balance as of period end2012-12-31-$1.07M-654.0%2015-03-24Balance as of period end2011-12-31$193.1K—2014-03-04Balance as of period end2011-08-10$0—2014-03-04Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)